{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:55:55Z","timestamp":1790207755514,"version":"4.1.0"},"reference-count":81,"publisher":"Informa UK Limited","issue":"39","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.2217\/fon-2023-0098","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:15:40Z","timestamp":1703081740000},"page":"2607-2621","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Molecular Targeted and Systemic Therapy for Intrahepatic Cholangiocarcinoma: a Multi-Disciplinary Approach"],"prefix":"10.1080","volume":"19","author":[{"given":"Katiuscha","family":"Merath","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology, University of Texas Health Science Center San Antonio MD Anderson Cancer Center, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, University of Texas Health Science Center San Antonio MD Anderson Cancer Center, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A","family":"Parikh","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, University of Texas Health Science Center San Antonio MD Anderson Cancer Center, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-9870","authenticated-orcid":false,"given":"Timothy M","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, The Ohio State University Wexner Medical Center & James Comprehensive Cancer Center, Columbus, OH43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0446"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-016-0527-z"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2013.5137"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010104"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.03.024"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.013"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00300-2"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14095"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.5009\/gnl15568"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04067.x"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.022"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186643"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.03.004"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2016.04.001"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1094-7"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.146.4.729"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.16.16923"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2016.12.10"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-4005-8"},{"issue":"5","key":"e_1_3_4_22_1","first-page":"2551","article-title":"Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer","volume":"34","author":"Park MS","year":"2014","unstructured":"Park MS , LeeSM. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer. Anticancer Res.34(5), 2551\u20132554 (2014).","journal-title":"Anticancer Res."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12441"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2014.09.002"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.001"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0245"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2017.11.006"},{"issue":"1","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9010005","article-title":"Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer","volume":"9","author":"McAnena P","year":"2017","unstructured":"McAnena P , BrownJA, KerinMJ. Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer. Cancers (Basel)9(1), (2017).","journal-title":"Cancers (Basel)"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2015.00013"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2016.10.03"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvac121"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082277"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12727"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00324"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.09.150"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206834"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00050"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30915-X"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.4097"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30157-1"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30109-1"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00196-5"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30321-1"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00762"},{"key":"e_1_3_4_45_1","article-title":"Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)","author":"Oh D","year":"2022","unstructured":"Oh D , HeAR, QinS, ChenL, OkusakaT, VogelAet al. Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC). ESMO (2022).","journal-title":"ESMO"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02568"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02178"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02038-4"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1498-0"},{"key":"e_1_3_4_50_1","unstructured":"Oxaliplatin + Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma. www.clinicaltrials.gov\/ct2\/show\/NCT02548195 (2nd January)."},{"key":"e_1_3_4_51_1","unstructured":"Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma. www.clinicaltrials.gov\/ct2\/show\/NCT04077983 (2nd January)."},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10641"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09536-w"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.03.023"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09478-3"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6610-4"},{"key":"e_1_3_4_57_1","unstructured":"Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma. www.clinicaltrials.gov\/ct2\/show\/NCT03603834 (2nd January)."},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz402"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.1219"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00679"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0270"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.4_suppl.LBA490"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30254"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0078"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.009"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0766"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0352"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.12.007"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0386"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.3836"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7087"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604129"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70301-1"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.4079"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00336-3"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00335-1"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00242-5"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.007"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820983013"},{"issue":"5","key":"e_1_3_4_81_1","article-title":"The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma","volume":"9","author":"Fiste O","year":"2021","unstructured":"Fiste O , Ntanasis-StathopoulosI, GavriatopoulouMet al. The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma. Vaccines (Basel)9(5), (2021).","journal-title":"Vaccines (Basel)"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030558"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200015"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2023-0098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T13:16:46Z","timestamp":1730899006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2023-0098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":81,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.2217\/fon-2023-0098"],"URL":"https:\/\/doi.org\/10.2217\/fon-2023-0098","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-02-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}